123 related articles for article (PubMed ID: 29890162)
1. Pathologic Markers Determining Prognosis in Patients With Treated or Healing Giant Cell Arteritis.
Sultan H; Smith SV; Lee AG; Chévez-Barrios P
Am J Ophthalmol; 2018 Sep; 193():45-53. PubMed ID: 29890162
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic correlations in giant cell arteritis: a retrospective study of 107 cases.
Zhou L; Luneau K; Weyand CM; Biousse V; Newman NJ; Grossniklaus HE
Ophthalmology; 2009 Aug; 116(8):1574-80. PubMed ID: 19500846
[TBL] [Abstract][Full Text] [Related]
3. Predictors for treatment success and expression of glucocorticoid receptor in giant cell arteritis and polymyalgia rheumatica.
Braun N; Fritz P; Rieth A; Schroth W; Kimmel M; Biegger D; Zakim D; Alscher MD
J Rheumatol; 2009 Oct; 36(10):2269-76. PubMed ID: 19684157
[TBL] [Abstract][Full Text] [Related]
4. The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis.
Jakobsson K; Jacobsson L; Mohammad AJ; Nilsson JÅ; Warrington K; Matteson EL; Turesson C
BMC Musculoskelet Disord; 2016 Aug; 17(1):363. PubMed ID: 27558589
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of giant cell arteritis using clinical, laboratory, and histopathological findings in patients undergoing temporal artery biopsy.
Muniz Castro HM; Bhattacharjee MB; Chaudhry IA; Chuang AZ; Mankiewicz KA; Adesina OO
Clin Neurol Neurosurg; 2022 Oct; 221():107377. PubMed ID: 35932586
[TBL] [Abstract][Full Text] [Related]
6. Temporal small-vessel inflammation in patients with giant cell arteritis: clinical course and preliminary immunohistopathologic characterization.
Belilos E; Maddox J; Kowalewski RM; Kowalewska J; Turi GK; Nochomovitz LE; Khan Y; Carsons SE
J Rheumatol; 2011 Feb; 38(2):331-8. PubMed ID: 21123318
[TBL] [Abstract][Full Text] [Related]
7. Increased rho kinase activity in temporal artery biopsies from patients with giant cell arteritis.
Lally L; Pernis A; Narula N; Huang WT; Spiera R
Rheumatology (Oxford); 2015 Mar; 54(3):554-8. PubMed ID: 25213129
[TBL] [Abstract][Full Text] [Related]
8. Temporal artery biopsy is not required in all cases of suspected giant cell arteritis.
Quinn EM; Kearney DE; Kelly J; Keohane C; Redmond HP
Ann Vasc Surg; 2012 Jul; 26(5):649-54. PubMed ID: 22285348
[TBL] [Abstract][Full Text] [Related]
9. Histopathologic Findings of Patients With Biopsy-Negative Giant Cell Arteritis Compared to Those Without Arteritis: A Population-Based Study.
Muratore F; Cavazza A; Boiardi L; Lo Gullo A; Pipitone N; Germanò G; Bisagni A; Cimino L; Salvarani C
Arthritis Care Res (Hoboken); 2016 Jun; 68(6):865-70. PubMed ID: 26415044
[TBL] [Abstract][Full Text] [Related]
10. Value of temporal artery biopsy length in diagnosing giant cell arteritis.
Oh LJ; Wong E; Gill AJ; McCluskey P; Smith JEH
ANZ J Surg; 2018 Mar; 88(3):191-195. PubMed ID: 27800647
[TBL] [Abstract][Full Text] [Related]
11. Correlations between histopathological findings and clinical manifestations in biopsy-proven giant cell arteritis.
Muratore F; Boiardi L; Cavazza A; Aldigeri R; Pipitone N; Restuccia G; Bellafiore S; Cimino L; Salvarani C
J Autoimmun; 2016 May; 69():94-101. PubMed ID: 27009904
[TBL] [Abstract][Full Text] [Related]
12. Giant cell arteritis: diagnostic accuracy of MR imaging of superficial cranial arteries in initial diagnosis-results from a multicenter trial.
Klink T; Geiger J; Both M; Ness T; Heinzelmann S; Reinhard M; Holl-Ulrich K; Duwendag D; Vaith P; Bley TA
Radiology; 2014 Dec; 273(3):844-52. PubMed ID: 25102371
[TBL] [Abstract][Full Text] [Related]
13. Characterization of serological markers of healed/healing arteritis and giant cell arteritis.
Kansal V; Han S; Farmer J; Albreiki D
Can J Ophthalmol; 2018 Feb; 53(1):39-44. PubMed ID: 29426439
[TBL] [Abstract][Full Text] [Related]
14. Temporal artery enhancement on cranial magnetic resonance imaging.
Al-Zubidi N; Mai C; Haykal HA; Lee AG
Can J Ophthalmol; 2014 Jun; 49(3):e63-5. PubMed ID: 24862784
[No Abstract] [Full Text] [Related]
15. MicroRNA markers of inflammation and remodelling in temporal arteries from patients with giant cell arteritis.
Croci S; Zerbini A; Boiardi L; Muratore F; Bisagni A; Nicoli D; Farnetti E; Pazzola G; Cimino L; Moramarco A; Cavazza A; Casali B; Parmeggiani M; Salvarani C
Ann Rheum Dis; 2016 Aug; 75(8):1527-33. PubMed ID: 26342092
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory Cell Composition and Immune-Related microRNA Signature of Temporal Artery Biopsies From Patients With Giant Cell Arteritis.
Bolha L; Hočevar A; Suljič A; Jurčić V
Front Immunol; 2021; 12():791099. PubMed ID: 35003111
[TBL] [Abstract][Full Text] [Related]
17. Temporal arteritis: a dilemma in clinical and pathological diagnosis.
Gooi P; Brownstein S; Rawlings N
Can J Ophthalmol; 2008 Feb; 43(1):119-20. PubMed ID: 18219354
[No Abstract] [Full Text] [Related]
18. Dysregulated Expression of Arterial MicroRNAs and Their Target Gene Networks in Temporal Arteries of Treatment-Naïve Patients with Giant Cell Arteritis.
Kuret T; Lakota K; Čučnik S; Jurčič V; Distler O; Rotar Ž; Hočevar A; Sodin-Šemrl S; Frank-Bertoncelj M
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204585
[TBL] [Abstract][Full Text] [Related]
19. Baseline clinical predictors of an ultimate giant cell arteritis diagnosis in patients referred to temporal artery biopsy.
Grossman C; Barshack I; Koren-Morag N; Ben-Zvi I; Bornstein G
Clin Rheumatol; 2016 Jul; 35(7):1817-22. PubMed ID: 26925851
[TBL] [Abstract][Full Text] [Related]
20. CD3 immunohistochemistry is helpful in the diagnosis of giant cell arteritis.
Ciccia F; Ferrante A; Guggino G; Cavazza A; Salvarani C; Rizzo A
Rheumatology (Oxford); 2018 Aug; 57(8):1377-1380. PubMed ID: 29697809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
